Dhruva Biswas MD PhD
Translational Science Lead at Ataraxis AI
Visiting Professor at King's College London
Research
My scientific focus→ is translating frontier genomic and AI technologies into meaningful patient benefit.
Selected articles:
- Biswas et al. Nature Medicine (2019). A Clonal Expression Biomarker Associates with Lung Cancer Mortality.
- Biswas et al The Lancet Oncology (2020). The Future of Liquid Biopsy.
- Wu*, Biswas* et al. Nature Cancer (2022). A Local Human Vδ1 T Cell Population Is Associated with Survival in Nonsmall-Cell Lung Cancer.
- Biswas et al. Nature Cancer (2025). Prospective Validation of ORACLE, a Clonal Expression Biomarker Associated with Survival of Patients with Lung Adenocarcinoma.
- Biswas et al. Nature Cancer (2025). Refining Biomarker Design in Light of Cancer Evolution.
- Biswas et al. European Heart Journal - Digital Health (2025). Racial and Ethnic Disparities in Aortic Stenosis within a Universal Healthcare System Characterised by Natural Language Processing for Targeted Intervention.
- Biswas et al. JACC: Advances (2025). Artificial Intelligence for Cardiovascular Care in Action: From Learning to Implementation in Health Systems.
News
Biography
I began my medical training at the University of Cambridge in 2012, earning an MA in Neuroscience in 2015. I then joined the MB/PhD program at University College London, conducting PhD research between the UCL Cancer Institute and the Francis Crick Institute. I graduated with PhD and MBBS degrees in 2022, then undertook an Academic Foundation training position in Cardiology at King’s College London while also working as a Postdoctoral Fellow at University College London. In 2024, I joined Yale University as a Faculty member in the School of Medicine, and King’s College London as a Visiting Professor. In 2026, I joined Ataraxis AI as Translational Science Lead, and BMJ Heart as an Editorial Board Member.
My investigator-led research has secured more than £600,000 (>$800,000) in competitive funding. My work translating frontier science into clinical utility has been recognized by several awards, including selection as a Francis Crick Institute Translation Fellow in recognition of my role-model contributions to translational medicine, as well as international presentation prizes. Beyond the lab, my commitment to clinical excellence has been recognized with a Medical Leadership Award.
Alongside my scientific and clinical responsibilities, I am passionate about mentorship and community engagement. I have supervised BSc, MSc and PhD trainees. Among MSc supervisees, all achieved distinction grades, with three nominated for the Dean’s Research Prize for top project marks in their cohorts. I am also committed to patient and public involvement, working with structural heart teams across London to increase access to life-prolonging procedures.